Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-015330
Filing Date
2025-05-08
Accepted
2025-05-08 11:51:12
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q veru20250331_10q.htm   iXBRL 10-Q 1571730
2 EXHIBIT 10.1 ex_781181.htm EX-10.1 14405
3 EXHIBIT 10.2 ex_811737.htm EX-10.2 15709
4 EXHIBIT 31.1 ex_781182.htm EX-31.1 9085
5 EXHIBIT 31.2 ex_781183.htm EX-31.2 9088
6 EXHIBIT 32.1 ex_781184.htm EX-32.1 6214
  Complete submission text file 0001437749-25-015330.txt   7753604

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA veru-20250331.xsd EX-101.SCH 63266
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE veru-20250331_cal.xml EX-101.CAL 59454
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE veru-20250331_def.xml EX-101.DEF 508292
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20250331_lab.xml EX-101.LAB 418707
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20250331_pre.xml EX-101.PRE 528917
78 EXTRACTED XBRL INSTANCE DOCUMENT veru20250331_10q_htm.xml XML 1131422
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 25924831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)